These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 10832024)

  • 1. Chloride-dependent inhibition of vesicular glutamate uptake by alpha-keto acids accumulated in maple syrup urine disease.
    Reis M; Farage M; Wolosker H
    Biochim Biophys Acta; 2000 Jul; 1475(2):114-8. PubMed ID: 10832024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease.
    Tavares RG; Santos CE; Tasca CI; Wajner M; Souza DO; Dutra-Filho CS
    J Neurol Sci; 2000 Dec; 181(1-2):44-9. PubMed ID: 11099711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of glutamate uptake into cerebral cortex of developing rats by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
    Funchal C; Rosa AM; Wajner M; Wofchuk S; Pureur RP
    Neurochem Res; 2004 Apr; 29(4):747-53. PubMed ID: 15098937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic plasma membrane Na(+), K (+)-ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortex.
    Wajner A; Bürger C; Dutra-Filho CS; Wajner M; de Souza Wyse AT; Wannmacher CM
    Metab Brain Dis; 2007 Mar; 22(1):77-88. PubMed ID: 17295076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease.
    Sgaravatti AM; Rosa RB; Schuck PF; Ribeiro CA; Wannmacher CM; Wyse AT; Dutra-Filho CS; Wajner M
    Biochim Biophys Acta; 2003 Nov; 1639(3):232-8. PubMed ID: 14636955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamate transport into synaptic vesicles. Roles of membrane potential, pH gradient, and intravesicular pH.
    Tabb JS; Kish PE; Van Dyke R; Ueda T
    J Biol Chem; 1992 Aug; 267(22):15412-8. PubMed ID: 1353494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells.
    Funchal C; Tramontina F; Quincozes dos Santos A; Fraga de Souza D; Gonçalves CA; Pessoa-Pureur R; Wajner M
    J Neurol Sci; 2007 Sep; 260(1-2):87-94. PubMed ID: 17499767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
    Amaral AU; Wajner M
    Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that the branched-chain alpha-keto acids accumulating in maple syrup urine disease induce morphological alterations and death in cultured astrocytes from rat cerebral cortex.
    Funchal C; Gottfried C; De Almeida LM; Wajner M; Pessoa-Pureur R
    Glia; 2004 Nov; 48(3):230-40. PubMed ID: 15390119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats.
    Bridi R; Braun CA; Zorzi GK; Wannmacher CM; Wajner M; Lissi EG; Dutra-Filho CS
    Metab Brain Dis; 2005 Jun; 20(2):155-67. PubMed ID: 15938133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the solubilized and reconstituted ATP-dependent vesicular glutamate uptake system.
    Carlson MD; Kish PE; Ueda T
    J Biol Chem; 1989 May; 264(13):7369-76. PubMed ID: 2523394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
    Funchal C; Latini A; Jacques-Silva MC; Dos Santos AQ; Buzin L; Gottfried C; Wajner M; Pessoa-Pureur R
    Neurochem Int; 2006 Dec; 49(7):640-50. PubMed ID: 16822590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of L-glutamate into rat brain synaptic vesicles: effect of inhibitors that bind specifically to the glutamate transporter.
    Roseth S; Fykse EM; Fonnum F
    J Neurochem; 1995 Jul; 65(1):96-103. PubMed ID: 7790899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organic acids and branched-chain amino acids in body fluids before and after multiple exchange transfusions in maple syrup urine disease.
    Shigematsu Y; Kikuchi K; Momoi T; Sudo M; Kikawa Y; Nosaka K; Kuriyama M; Haruki S; Sanada K; Hamano N
    J Inherit Metab Dis; 1983; 6(4):183-9. PubMed ID: 6422161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatine and antioxidant treatment prevent the inhibition of creatine kinase activity and the morphological alterations of C6 glioma cells induced by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
    Funchal C; Schuck PF; Santos AQ; Jacques-Silva MC; Gottfried C; Pessoa-Pureur R; Wajner M
    Cell Mol Neurobiol; 2006 Feb; 26(1):67-79. PubMed ID: 16633902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood and tissue branched-chain amino and alpha-keto acid concentrations: effect of diet, starvation, and disease.
    Hutson SM; Harper AE
    Am J Clin Nutr; 1981 Feb; 34(2):173-83. PubMed ID: 7211722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
    Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
    Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease.
    Jouvet P; Rustin P; Taylor DL; Pocock JM; Felderhoff-Mueser U; Mazarakis ND; Sarraf C; Joashi U; Kozma M; Greenwood K; Edwards AD; Mehmet H
    Mol Biol Cell; 2000 May; 11(5):1919-32. PubMed ID: 10793161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of glutamate transport into synaptic vesicles by chloride and proton gradient.
    Wolosker H; de Souza DO; de Meis L
    J Biol Chem; 1996 May; 271(20):11726-31. PubMed ID: 8662610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active transport of gamma-aminobutyric acid and glycine into synaptic vesicles.
    Kish PE; Fischer-Bovenkerk C; Ueda T
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3877-81. PubMed ID: 2566998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.